🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers Irish medicines CAMCEVI 21 mg prolonged-release suspension for injection
Medicines register · Ireland

CAMCEVI 21 mg prolonged-release suspension for injection

Authorisation EU/1/22/1647/002 · Accord Healthcare S.L.U.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. Published 16 Sep 2026
Licence holder
Accord Healthcare S.L.U. (all products →)
Active substance
Leuprorelin mesilate
Dosage form
Prolonged-release suspension for injection
Route of administration
Subcutaneous use
ATC code
L02AE02
First authorised
20/04/2026
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Hybrid application (Article 10(3) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.